Why the study?
Does Bazett's formula perform as well as newer QTc correction formulas in identifying SCN5A mutation carriers in a family with Long QT Syndrome Type 3?
Population
101 adult members of a large family with Long QT Syndrome Type 3, including 57 carriers and 44 noncarriers.
Comparison
QT interval correction using Bazett's formula… vs Comparison among different QTc formulas and…
Design
Cross-sectional
Authors
Loading...
Supports Bazett's plus low-rate Holter for LQTS3 carrier detection; leaves open validation in larger, diverse cohorts.
Does Bazett's formula perform as well as newer QTc correction formulas in identifying SCN5A mutation carriers in a family with Long QT Syndrome Type 3?
Bazett's formula is as effective as newer QTc correction formulas for identifying SCN5A mutation carriers in LQTS3, especially when combined with 24-hour Holter monitoring at low heart rates.
Brouwer et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: